Welcome Joe Zock to IntelliCyt
Author: Linda Trinkle; Published: Jul 29, 2011; Category: Drug Discovery, Flow Cytometry; Tags: None; 2 Comments
With great pleasure I announce that Joe Zock has joined IntelliCyt as the Senior Director of Product Management. I still can’t believe it is true. I first met Joe at SBS in 2007 when Terry Dunlay, our CEO, and I went to the conference with our fledgling company and presented our first poster. We were wandering through the exhibit hall, greeting old friends and running into former co-workers, noting that cytometry is a field of increasing mobility. One year, a person is working in flow cytometry, a few years later, image cytometry and that the edges between technologies and employees in each field were beginning to blur. We talked to Joe for a while, and as we walked around the exhibit hall, Terry shared some stories of how he and Joe made things happen in the early days of Cellomics—defining the field of High Content Screening and developing a new market.
Over the next few years, we would run into Joe at increasing numbers of meetings as we grew the company and started attending more conferences. I learned that Joe is a passionate scientist who knew a lot and cared even more about the role and importance of cell-based screening in drug development. Every now and then, it would come up in our internal discussions how we could use a guy like Joe to help us close the gap between flow cytometry and image cytometry by moving flow into screening with suspension assays. I read an article that Joe wrote in 2009, where he said, “The search is on for better tools that can automate discovery processes and yet provide the innovation needed to explore therapies for existing and emerging diseases.” Yep, we thought Joe would fit right in at IntelliCyt.
So, after two weeks working with Joe, I am happy to say that we have a remarkably capable and knowledgeable addition to our team and I think our customers and the scientific community will benefit with the addition of such a champion of cell-based screening to the IntelliCyt team. Go Joe!
